Antidepressant effects of ketamine and the roles of AMPA glutamate receptors and other mechanisms beyond NMDA receptor antagonism

Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies

Lang, U. E., & Borgwardt, S. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350094 · Cited by 8,501 · see citing works

Antidepressant effects of ketamine in depressed patients

Berman, R. M., Cappiello, A., Anand, A., Oren, D. A., Heninger, G. R., Charney, D. S., & Krystal, J. H. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00230-9 · Cited by 3,856 · see citing works

mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists

Li, N., Lee, B., Liu, R.-J., Banasr, M., Dwyer, J. M., Iwata, M., Li, X.-Y., Aghajanian, G., & Duman, R. S. (2010) · Science · doi:10.1126/science.1190287 · Cited by 2,881 · see citing works

NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses

Autry, A. E., Adachi, M., Nosyreva, E., Na, E. S., Los, M. F., Cheng, P.-F., Kavalali, E. T., & Monteggia, L. M. (2011) · Nature · doi:10.1038/nature10130 · Cited by 1,926 · see citing works

Activation of Glutamatergic Neurotransmission by Ketamine: A Novel Step in the Pathway from NMDA Receptor Blockade to Dopaminergic and Cognitive Disruptions Associated with the Prefrontal Cortex

Moghaddam, B., Adams, B., Verma, A., & Daly, D. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-08-02921.1997 · Cited by 1,793 · see citing works

Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants

Duman, R. S., Aghajanian, G. K., Sanacora, G., & Krystal, J. H. (2016) · Nature Medicine · doi:10.1038/nm.4050 · Cited by 1,750 · see citing works

Synaptic Dysfunction in Depression: Potential Therapeutic Targets

Duman, R. S., & Aghajanian, G. K. (2012) · Science · doi:10.1126/science.1222939 · Cited by 1,651 · see citing works

NMDAR inhibition-independent antidepressant actions of ketamine metabolites

Zanos, P., Moaddel, R., Morris, P. J., Georgiou, P., Fischell, J., Elmer, G. I., Alkondon, M., Yuan, P., Pribut, H. J., Singh, N. S., et al. (2016) · Nature · doi:10.1038/nature17998 · Cited by 1,609 · see citing works

Cellular Mechanisms Underlying the Antidepressant Effects of Ketamine: Role of α-Amino-3-Hydroxy-5-Methylisoxazole-4-Propionic Acid Receptors

Maeng, S., Zarate, C. A., Du, J., Schloesser, R. J., McCammon, J., Chen, G., & Manji, H. K. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.05.028 · Cited by 1,103 · see citing works

Glutamate N-methyl-D-aspartate Receptor Antagonists Rapidly Reverse Behavioral and Synaptic Deficits Caused by Chronic Stress Exposure

Li, N., Liu, R.-J., Dwyer, J. M., Banasr, M., Lee, B., Son, H., Li, X.-Y., Aghajanian, G., & Duman, R. S. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.12.015 · Cited by 1,082 · see citing works

BDNF - a key transducer of antidepressant effects

Björkholm, C., & Monteggia, L. M. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.10.034 · Cited by 958 · see citing works

R-ketamine: a rapid-onset and sustained antidepressant without psychotomimetic side effects

Yang, C., Shirayama, Y., Zhang, J.-C., Ren, Q., Yao, W., Ma, M., Dong, C., & Hashimoto, K. (2015) · Translational Psychiatry · doi:10.1038/tp.2015.136 · Cited by 605 · see citing works

Ketamine and other NMDA antagonists: early clinical trials and possible mechanisms in depression.

Newport, D. J., Carpenter, L. L., McDonald, W. M., Potash, J. B., Tohen, M., Nemeroff, C. B., & The APA Council of Research Task Force on Novel Biomarkers and Treatments (2015) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2015.15040465 · Cited by 598 · see citing works

Signaling pathways underlying the rapid antidepressant actions of ketamine

Duman, R. S., Li, N., Liu, R.-J., Duric, V., & Aghajanian, G. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.08.044 · Cited by 537 · see citing works

Ketamine for chronic pain: risks and benefits

Niesters, M., Martini, C. H., & Dahan, A. (2013) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12094 · Cited by 514 · see citing works

Ketamine and Rapid-Acting Antidepressants: A Window into a New Neurobiology for Mood Disorder Therapeutics

Abdallah, C. G., Sanacora, G., Duman, R. S., & Krystal, J. H. (2015) · Annual Review of Medicine · doi:10.1146/annurev-med-053013-062946 · Cited by 422 · see citing works

Abnormal Glutamate Receptor Expression in the Medial Temporal Lobe in Schizophrenia and Mood Disorders

Beneyto, M., Kristiansen, L. V., Oni-Orisan, A., McCullumsmith, R. E., & Meador-Woodruff, J. H. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301312 · Cited by 408 · see citing works

Chronic stress, as well as acute stress, reduces BDNF mRNA expression in the rat hippocampus but less robustly

Murakami, S., Imbe, H., Morikawa, Y., Kubo, C., & Senba, E. (2005) · Neuroscience Research · doi:10.1016/j.neures.2005.06.008 · Cited by 398 · see citing works

Ketamine-induced antidepressant effects are associated with AMPA receptors-mediated upregulation of mTOR and BDNF in rat hippocampus and prefrontal cortex

Zhou, W., Wang, N., Yang, C., Li, X.-M., Zhou, Z.-Q., & Yang, J.-J. (2014) · European Psychiatry · doi:10.1016/j.eurpsy.2013.10.005 · Cited by 390 · see citing works

Single-dose infusion ketamine and non-ketamine <i>N</i> -methyl- <scp>d</scp> -aspartate receptor antagonists for unipolar and bipolar depression: a meta-analysis of efficacy, safety and time trajectories

Kishimoto, T., Chawla, J. M., Hagi, K., Zarate, C. A., Kane, J. M., Bauer, M., & Correll, C. U. (2016) · Psychological Medicine · doi:10.1017/s0033291716000064 · Cited by 359 · see citing works

Involvement of AMPA receptor in both the rapid and sustained antidepressant-like effects of ketamine in animal models of depression

Koike, H., Iijima, M., & Chaki, S. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2011.05.035 · Cited by 346 · see citing works

Altered expression of synapse and glutamate related genes in post-mortem hippocampus of depressed subjects

Duric, V., Banasr, M., Stockmeier, C. A., Simen, A. A., Newton, S. S., Overholser, J. C., Jurjus, G. J., Dieter, L., & Duman, R. S. (2013) · International Journal of Neuropsychopharmacology · doi:10.1017/s1461145712000016 · Cited by 304 · see citing works

Emerging treatment mechanisms for depression: focus on glutamate and synaptic plasticity

Gerhard, D. M., Wohleb, E. S., & Duman, R. S. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2016.01.016 · Cited by 287 · see citing works

GLYX-13, a NMDA Receptor Glycine-Site Functional Partial Agonist, Induces Antidepressant-Like Effects Without Ketamine-Like Side Effects

Burgdorf, J., Zhang, X.-L., Nicholson, K. L., Balster, R. L., David Leander, J., Stanton, P. K., Gross, A. L., Kroes, R. A., & Moskal, J. R. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2012.246 · Cited by 284 · see citing works

Stress, anxiety, and dendritic spines: What are the connections?

Leuner, B., & Shors, T. J. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2012.04.021 · Cited by 284 · see citing works

Acute suppression of spontaneous neurotransmission drives synaptic potentiation

Nosyreva, E., Szabla, K., Autry, A. E., Ryazanov, A. G., Monteggia, L. M., & Kavalali, E. T. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.4998-12.2013 · Cited by 283 · see citing works

Relationship of ketamine's plasma metabolites with response, diagnosis, and side effects in major depression

Zarate, C. A., Brutsche, N., Laje, G., Luckenbaugh, D. A., Venkata, S. L. V., Ramamoorthy, A., Moaddel, R., & Wainer, I. W. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.03.004 · Cited by 282 · see citing works

Ketamine and the next generation of antidepressants with a rapid onset of action

Machado‐Vieira, R., Salvadore, G., Diazgranados, N., & Zarate, C. A. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.02.010 · Cited by 275 · see citing works

Sex differences in the antidepressant-like effects of ketamine

Carrier, N., & Kabbaj, M. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.12.009 · Cited by 251 · see citing works

Animal models as tools to study the pathophysiology of depression

Abelaira, H. M., Réus, G. Z., & Quevedo, J. (2013) · Brazilian Journal of Psychiatry · doi:10.1590/1516-4446-2013-1098 · Cited by 236 · see citing works

Innovative approaches for the development of antidepressant drugs: Current and future strategies

Schechter, L. E., Ring, R. H., Beyer, C. E., Hughes, Z. A., Khawaja, X. Z., Malberg, J. E., & Rosenzweig-Lipson, S. J. (2005) · NeuroRx · doi:10.1602/neurorx.2.4.590 · Cited by 229 · see citing works

Antidepressant-like actions of an AMPA receptor potentiator (LY392098)

Li, X., Tizzano, J. P., Griffey, K., Clay, M., Lindstrom, T., & Skolnick, P. (2001) · Neuropharmacology · doi:10.1016/s0028-3908(00)00194-5 · Cited by 225 · see citing works

The Anticonvulsants Lamotrigine, Riluzole, and Valproate Differentially Regulate AMPA Receptor Membrane Localization: Relationship to Clinical Effects in Mood Disorders

Du, J., Suzuki, K., Wei, Y., Wang, Y., Blumenthal, R., Chen, Z., Falke, C., Zarate, C. A., & Manji, H. K. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301178 · Cited by 208 · see citing works

KETAMINE'S MECHANISM OF ACTION: A PATH TO RAPID‐ACTING ANTIDEPRESSANTS

Abdallah, C. G., Adams, T. G., Kelmendi, B., Esterlis, I., Sanacora, G., & Krystal, J. H. (2016) · Depression and Anxiety · doi:10.1002/da.22501 · Cited by 206 · see citing works

Transiently increased glutamate cycling in rat PFC is associated with rapid onset of antidepressant-like effects

Chowdhury, G. M. I., Zhang, J., Thomas, M., Banasr, M., Ma, X., Pittman, B., Bristow, L., Schaeffer, E., Duman, R. S., Rothman, D. L., et al. (2017) · Molecular Psychiatry · doi:10.1038/mp.2016.34 · Cited by 197 · see citing works

Age‐dependent effects of chronic stress on brain plasticity and depressive behavior

Tóth, E., Gersner, R., Wilf‐Yarkoni, A., Raizel, H., Dar, D. E., Richter‐Levin, G., Levit, O., & Zangen, A. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05642.x · Cited by 193 · see citing works

Sub-anesthetic concentrations of (R, S)-ketamine metabolites inhibit acetylcholine-evoked currents in α7 nicotinic acetylcholine receptors

Moaddel, R., Abdrakhmanova, G., Kozak, J., Jozwiak, K., Toll, L., Jimenez, L., Rosenberg, A., Tran, T., Xiao, Y., Zarate, C. A., et al. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2012.11.023 · Cited by 176 · see citing works

Acute administration of ketamine in rats increases hippocampal BDNF and mTOR levels during forced swimming test

Yang, C., Hu, Y.-M., Zhou, Z.-Q., Zhang, G.-F., & Yang, J.-J. (2013) · Upsala Journal of Medical Sciences · doi:10.3109/03009734.2012.724118 · Cited by 173 · see citing works

Antidepressant-like effects of low ketamine dose is associated with increased hippocampal AMPA/NMDA receptor density ratio in female Wistar–Kyoto rats

Tizabi, Y., Bhatti, B. H., Manaye, K. F., Das, J. R., & Akinfiresoye, L. R. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.03.052 · Cited by 172 · see citing works

New perspectives on the involvement of mTOR in depression as well as in the action of antidepressant drugs

Ignácio, Z. M., Réus, G. Z., Arent, C. O., Abelaira, H. M., Pitcher, M. R., & Quevedo, J. (2015) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12845 · Cited by 172 · see citing works

Ketamine: Promising Path or False Prophecy in the Development of Novel Therapeutics for Mood Disorders?

Sanacora, G., & Schatzberg, A. F. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2014.261 · Cited by 160 · see citing works

Requirement of AMPA receptor stimulation for the sustained antidepressant activity of ketamine and LY341495 during the forced swim test in rats

Koike, H., & Chaki, S. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.05.065 · Cited by 157 · see citing works

New targets for rapid antidepressant action

Machado‐Vieira, R., Henter, I. D., & Zarate, C. A. (2015) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.12.001 · Cited by 156 · see citing works

Antidepressant effects of AMPA and ketamine combination: role of hippocampal BDNF, synapsin, and mTOR

Akinfiresoye, L. R., & Tizabi, Y. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3153-2 · Cited by 149 · see citing works

Expanding the horizons of depression: beyond the monoamine hypothesis

Hindmarch, I. (2001) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.288 · Cited by 143 · see citing works

AMPA receptor stimulation mediates the antidepressant-like effect of a group II metabotropic glutamate receptor antagonist

Karasawa, J.-I., Shimazaki, T., Kawashima, N., & Chaki, S. (2005) · Brain Research · doi:10.1016/j.brainres.2005.02.032 · Cited by 131 · see citing works

Ketamine enantiomers in the rapid and sustained antidepressant effects

Muller, J., Pentyala, S., Dilger, J., & Pentyala, S. (2016) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125316631267 · Cited by 122 · see citing works

Ketamine for treatment-resistant depression: recent developments and clinical applications

Kirshenbaum, J. S., Murrough, J. W., & Iosifescu, D. V. (2016) · Evidence-Based Mental Health · doi:10.1136/eb-2016-102355 · Cited by 117 · see citing works

The antidepressant-like effects of glutamatergic drugs ketamine and AMPA receptor potentiator LY 451646 are preserved in bdnf+/− heterozygous null mice

Lindholm, J., Autio, H., Vesa, L., Antila, H., Lindemann, L., Hoener, M. C., Skolnick, P., Rantamäki, T., & Ċastrén, E. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.08.015 · Cited by 102 · see citing works

The role of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors in depression: Central mediators of pathophysiology and antidepressant activity?

Freudenberg, F., Celikel, T., & Reif, A. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.03.005 · Cited by 92 · see citing works

Comparison of R-ketamine and rapastinel antidepressant effects in the social defeat stress model of depression

Yang, B., Zhang, J.-C., Han, M., Yao, W., Yang, C., Ren, Q., Ma, M., Chen, Q.-X., & Hashimoto, K. (2016) · Psychopharmacology · doi:10.1007/s00213-016-4399-2 · Cited by 91 · see citing works

The Role of GluN2A and GluN2B Subunits on the Effects of NMDA Receptor Antagonists in Modeling Schizophrenia and Treating Refractory Depression

Jiménez-Sánchez, L., Campa, L., Auberson, Y. P., & Adell, A. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.123 · Cited by 78 · see citing works

Impact of subanesthetic doses of ketamine on AMPA-mediated responses in rats: An <i>in vivo</i> electrophysiological study on monoaminergic and glutamatergic neurons

El Iskandrani, K. S., Oosterhof, C. A., El Mansari, M., & Blier, P. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881115573809 · Cited by 75 · see citing works

Examination of Org 26576, an AMPA receptor positive allosteric modulator, in patients diagnosed with major depressive disorder: an exploratory, randomized, double-blind, placebo-controlled trial

Nations, K. R., Dogterom, P., Bursi, R., Schipper, J., Greenwald, S. D., Zraket, D., Gertsik, L., Johnstone, J., Lee, A. T. C., Pande, Y., et al. (2012) · Journal of Psychopharmacology · doi:10.1177/0269881112458728 · Cited by 74 · see citing works

Repeated ketamine treatment induces sex-specific behavioral and neurochemical effects in mice

Thelen, C., Sens, J. P., Mauch, J., Pandit, R., & Pitychoutis, P. M. (2016) · Behavioural Brain Research · doi:10.1016/j.bbr.2016.06.041 · Cited by 74 · see citing works

What Are the Implications of the STAR*D Trial for Primary Care?

Huynh, N., & McIntyre, R. S. (2008) · The Primary Care Companion to The Journal of Clinical Psychiatry · doi:10.4088/pcc.v10n0201 · Cited by 72 · see citing works

Enhancing AMPA to NMDA throughput as a convergent mechanism for antidepressant action

Du, J., Machado-Vieira, R., Maeng, S., Martinowich, K., Manji, H. K., & Zarate, C. A. (2006) · Drug Discovery Today: Therapeutic Strategies · doi:10.1016/j.ddstr.2006.11.012 · Cited by 64 · see citing works

The effect of acute stress on LTP and LTD induction in the hippocampal CA1 region of anesthetized rats at three different ages

Xiong, W., Wei, H., Xiang, X., Cao, J., Dong, Z., Wang, Y., Xu, T., & Xu, L. (2004) · Brain Research · doi:10.1016/j.brainres.2004.01.051 · Cited by 44 · see citing works

Ketamine-like effects of a combination of olanzapine and fluoxetine on AMPA and NMDA receptor-mediated transmission in the medial prefrontal cortex of the rat

Björkholm, C., Jardemark, K., Schilström, B., & Svensson, T. H. (2015) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2015.07.002 · Cited by 42 · see citing works

Novel Glutamatergic Treatments for Severe Mood Disorders

Park, M., Niciu, M. J., & Zarate, C. A. (2015) · Current Behavioral Neuroscience Reports · doi:10.1007/s40473-015-0050-5 · Cited by 40 · see citing works

Glutamatergic NMDA Receptor as Therapeutic Target for Depression

Réus, G. Z., Abelaira, H. M., Tuon, T., Titus, S. E., Ignácio, Z. M., Rodrigues, A. L. S., & Quevedo, J. (2015) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2015.10.003 · Cited by 40 · see citing works

NR2B-containing N-methyl-D-aspartate subtype glutamate receptors regulate the acute stress effect on hippocampal long-term potentiation/long-term depression in vivo

Wang, M., Yang, Y., Dong, Z., Cao, J., & Xu, L. (2006) · Neuroreport · doi:10.1097/01.wnr.0000227994.07799.6c · Cited by 35 · see citing works

NMDAR inhibition-independent antidepressant actions of ketamine metabolites

Zanos, P. (2017) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(17)30999-9 · Cited by 35 · see citing works

Dendritic structural plasticity and neuropsychiatric disease

Forrest, M. P., Parnell, E., & Penzes, P. (2018) · Nature Reviews Neuroscience · doi:10.1038/nrn.2018.16 · Cited by 464 · see citing works

Dysregulation of adult hippocampal neuroplasticity in major depression: Pathogenesis and therapeutic implications

Tartt, A. N., Mariani, M. B., Hen, R., Mann, J. J., & Boldrini, M. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01520-y · Cited by 408 · see citing works

Comparative efficacy of racemic ketamine and esketamine for depression: A systematic review and meta-analysis

Bahji, A., Vazquez, G. H., & Zarate, C. A. (2021) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.09.071 · Cited by 408 · see citing works

Neuroplasticity as a convergent mechanism of ketamine and classical psychedelics

Aleksandrova, L. R., & Phillips, A. G. (2021) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2021.08.003 · Cited by 276 · see citing works

Psychedelics and Neuroplasticity: A Systematic Review Unraveling the Biological Underpinnings of Psychedelics.

de Vos, C. M. H., Mason, N. L., & Kuypers, K. P. C. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.724606 · Cited by 269 · see citing works

Hallucinogens in Mental Health: Preclinical and Clinical Studies on LSD, Psilocybin, MDMA, and Ketamine

Gregorio, D. D., Aguilar‐Valles, A., Preller, K. H., Heifets, B. D., Hibicke, M., Mitchell, J., & Gobbi, G. (2020) · Journal of Neuroscience · doi:10.1523/jneurosci.1659-20.2020 · Cited by 261 · see citing works

Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanisms

Inserra, A., De Gregorio, D., & Gobbi, G. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000056 · Cited by 232 · see citing works

Ketamine as an antidepressant: Overview of its mechanisms of action and potential predictive biomarkers

Matveychuk, D., Thomas, R. K., Swainson, J., Khullar, A., MacKay, M.-A., Baker, G. B., & Dursun, S. M. (2020) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125320916657 · Cited by 209 · see citing works

Understanding the mechanism of action and clinical effects of neuroactive steroids and GABAergic compounds in major depressive disorder

Cutler, A. J., Mattingly, G. W., & Maletic, V. (2023) · Translational Psychiatry · doi:10.1038/s41398-023-02514-2 · Cited by 147 · see citing works

Real-world experience of esketamine use to manage treatment-resistant depression: A multicentric study on safety and effectiveness (REAL-ESK study)

Martinotti, G., Vita, A., Fagiolini, A., Maina, G., Bertolino, A., Dell'Osso, B., Siracusano, A., Clerici, M., Bellomo, A., Sani, G., et al. (2022) · Journal of Affective Disorders · doi:10.1016/j.jad.2022.09.043 · Cited by 146 · see citing works

The molecular pathophysiology of depression and the new therapeutics

Tian, H., Hu, Z., Xu, J., & Wang, C. (2022) · MedComm · doi:10.1002/mco2.156 · Cited by 122 · see citing works

Depression: Biological markers and treatment

Erjavec, G. N., Šagud, M., Perković, M. N., Štrac, D. Š., Konjevod, M., Tudor, L., Uzun, S., & Pivac, N. (2020) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.110139 · Cited by 120 · see citing works

The Nucleus Accumbens: A Common Target in the Comorbidity of Depression and Addiction

Xu, L., Nan, J., & Lan, Y. (2020) · Frontiers in Neural Circuits · doi:10.3389/fncir.2020.00037 · Cited by 115 · see citing works

Evaluation of the Wistar-Kyoto rat model of depression and the role of synaptic plasticity in depression and antidepressant response

Aleksandrova, L. R., Wang, Y. T., & Phillips, A. G. (2019) · Neuroscience &amp; Biobehavioral Reviews · doi:10.1016/j.neubiorev.2019.07.007 · Cited by 114 · see citing works

Novel drug developmental strategies for treatment‐resistant depression

Borbély, É., Simon, M., Fuchs, E., Wiborg, O., Czéh, B., & Helyes, Z. (2021) · British Journal of Pharmacology · doi:10.1111/bph.15753 · Cited by 111 · see citing works

Perspectives for therapy of treatment‐resistant depression

Papp, M., Cubała, W. J., Święcicki, Ł., Newman‐Tancredi, A., & Willner, P. (2021) · British Journal of Pharmacology · doi:10.1111/bph.15596 · Cited by 92 · see citing works

Ketamine and its metabolite, (2R,6R)-HNK, restore hippocampal LTP and long-term spatial memory in the Wistar-Kyoto rat model of depression

Aleksandrova, L. R., Wang, Y. T., & Phillips, A. G. (2020) · Molecular Brain · doi:10.1186/s13041-020-00627-z · Cited by 85 · see citing works

The Psychedelic Future of Post-Traumatic Stress Disorder Treatment

Zaretsky, T. G., Jagodnik, K. M., Barsic, R., Antonio, J. H., Bonanno, P. A., MacLeod, C., Pierce, C., Carney, H., Morrison, M. T., Saylor, C. F., et al. (2024) · Current Neuropharmacology · doi:10.2174/1570159x22666231027111147 · Cited by 85 · see citing works

Ketamine decreases neuronally released glutamate via retrograde stimulation of presynaptic adenosine A1 receptors

Lazarevic, V., Yang, Y., Flais, I., & Svenningsson, P. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01246-3 · Cited by 76 · see citing works

Targeting inflammation: a potential approach for the treatment of depression

Bhatt, S., Devadoss, T., Jha, N. K., Baidya, M., Gupta, G., Chellappan, D. K., Singh, S. K., & Dua, K. (2022) · Metabolic Brain Disease · doi:10.1007/s11011-022-01095-1 · Cited by 81 · see citing works

Targeting Inflammatory-Mitochondrial Response in Major Depression: Current Evidence and Further Challenges

Visentin, A. P. V., Colombo, R., Scotton, E., Fracasso, D. S., Rosa, A. R., Branco, C. S., & Salvador, M. M. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/2972968 · Cited by 77 · see citing works

Inhibition of activated astrocyte ameliorates lipopolysaccharide- induced depressive-like behaviors

Wang, Y., Ni, J., Zhai, L., Gao, C., Xie, L., Zhao, L., & Yin, X. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.08.015 · Cited by 75 · see citing works

Ketamine activates adult-born immature granule neurons to rapidly alleviate depression-like behaviors in mice

Rawat, R., Tunc‐Ozcan, E., McGuire, T. L., Peng, C., & Kessler, J. A. (2022) · Nature Communications · doi:10.1038/s41467-022-30386-5 · Cited by 74 · see citing works

Efficacy and safety of racemic ketamine and esketamine for depression: a systematic review and meta-analysis

Bahji, A., Zarate, C. A., & Vázquez, G. H. (2022) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2022.2047928 · Cited by 73 · see citing works

Sex-specific neurobiological actions of prophylactic (R,S)-ketamine, (2R,6R)-hydroxynorketamine, and (2S,6S)-hydroxynorketamine

Chen, B. K., Luna, V. M., LaGamma, C. T., Xu, X., Deng, S., Suckow, R. F., Cooper, T. B., Shah, A., Brachman, R. A., Mendez‐David, I., et al. (2020) · Neuropsychopharmacology · doi:10.1038/s41386-020-0714-z · Cited by 68 · see citing works

A Review of Nonanesthetic Uses of Ketamine

Pribish, A. M., Wood, N. J., & Kalava, A. (2020) · Anesthesiology Research and Practice · doi:10.1155/2020/5798285 · Cited by 67 · see citing works

Modulation of amygdala reactivity following rapidly acting interventions for major depression

Loureiro, J. R., Leaver, A. M., Vasavada, M. M., Sahib, A. K., Kubicki, A., Joshi, S. H., Woods, R. P., Wade, B., Congdon, E. L., Espinoza, R. T., et al. (2020) · Human Brain Mapping · doi:10.1002/hbm.24895 · Cited by 63 · see citing works

Antidepressant mechanisms of ketamine: a review of actions with relevance to treatment-resistance and neuroprogression

Lullau, A. P. M., Haga, E. M. W., Ronold, E. H., & Dwyer, G. E. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1223145 · Cited by 63 · see citing works

Research progress on classical traditional chinese medicine formula xiaoyaosan in the treatment of depression

Chen, J., Lei, C., Li, X., Wu, Q., Liu, C., Ma, Q., & Chen, J. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.925514 · Cited by 60 · see citing works

Ketamine, Esketamine, and Arketamine: Their Mechanisms of Action and Applications in the Treatment of Depression and Alleviation of Depressive Symptoms

Kawczak, P., Feszak, I. J., & Bączek, T. (2024) · Biomedicines · doi:10.3390/biomedicines12102283 · Cited by 63 · see citing works

Ketamine as a Treatment for Anorexia Nervosa: A Narrative Review

Keeler, J. L., Treasure, J. L., Juruena, M. F., Kan, C., & Himmerich, H. (2021) · Nutrients · doi:10.3390/nu13114158 · Cited by 56 · see citing works

Alcohol Exposure Induces Depressive and Anxiety-like Behaviors via Activating Ferroptosis in Mice

Xu, C., Xiong, Q., Tian, X., Liu, W., Sun, B., Ru, Q., & Shu, X. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232213828 · Cited by 55 · see citing works

On the varieties of conscious experiences: Altered Beliefs Under Psychedelics (ALBUS)

Safron, A., Juliani, A., Reggente, N., Klimaj, V., & Johnson, M. W. (2025) · Neuroscience of Consciousness · doi:10.1093/nc/niae038 · Cited by 54 · see citing works

Understanding the Biological Relationship between Migraine and Depression

Viudez‐Martínez, A., Torregrosa, A. B., Navarrete, F., & García‐Gutiérrez, M. S. (2024) · Biomolecules · doi:10.3390/biom14020163 · Cited by 55 · see citing works

Sub-anesthetic and anesthetic ketamine produce different long-lasting behavioral phenotypes (24 h post-treatment) via inducing different brain-derived neurotrophic factor (BDNF) expression level in the hippocampus

Wu, C., Wang, Y., Yang, H., Wu, S., Xie, Z., Zhang, J., He, L., Wang, Z., & He, L. (2019) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2019.107136 · Cited by 50 · see citing works

Resilience Dysregulation in Major Depressive Disorder: Focus on Glutamatergic Imbalance and Microglial Activation

Réus, G. Z., de Moura, A. B., da Silva, R. H., Resende, W. R., & Quevedo, J. (2017) · Current Neuropharmacology · doi:10.2174/1570159x15666170630164715 · Cited by 50 · see citing works

Glutamatergic receptor and neuroplasticity in depression: Implications for ketamine and rapastinel as the rapid-acting antidepressants

Wang, Y., Zhang, N., Liu, L., Jiang, H., Hu, D., Wang, Z., Chen, N., & Zhang, Y. (2022) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2022.01.024 · Cited by 46 · see citing works

Activation of astrocytic sigma‐1 receptor exerts antidepressant‐like effect via facilitating <scp>CD38</scp>‐driven mitochondria transfer

Wang, Y., Ni, J., Gao, T., Gao, C., Guo, L., & Yin, X. (2020) · Glia · doi:10.1002/glia.23850 · Cited by 42 · see citing works

Ketamine: The final frontier or another depressing end?

Sial, O. K., Parise, E. M., Parise, L. F., Gnecco, T., & Bolaños‐Guzmán, C. A. (2020) · Behavioural Brain Research · doi:10.1016/j.bbr.2020.112508 · Cited by 40 · see citing works

Vesicular glutamate transporter 1 (VGLUT1)-mediated glutamate release and membrane GluA1 activation is involved in the rapid antidepressant-like effects of scopolamine in mice

Yu, H., Li, M., Zhou, D., Lv, D., Liao, Q., Lou, Z., Shen, M., Wang, Z., Li, M., Xiao, X., et al. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.12.028 · Cited by 40 · see citing works

A single intravenous administration of a sub-anesthetic ketamine dose during the perioperative period of cesarean section for preventing postpartum depression: A meta-analysis

Li, Q., Wang, S., & Mei, X. (2022) · Psychiatry Research · doi:10.1016/j.psychres.2022.114396 · Cited by 38 · see citing works

Neuroanatomical, Biochemical, and Functional Modifications in Brain Induced by Treatment with Antidepressants

Khushboo, Siddiqi, N. J., Pereira, M. D. L., & Sharma, B. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-02780-z · Cited by 39 · see citing works

Diversity of AMPA Receptor Ligands: Chemotypes, Binding Modes, Mechanisms of Action, and Therapeutic Effects

Golubeva, E. A., Lavrov, M. I., Radchenko, E. V., & Palyulin, V. A. (2022) · Biomolecules · doi:10.3390/biom13010056 · Cited by 37 · see citing works

Advancements Exploring Major Depressive Disorder: Insights on Oxidative Stress, Serotonin Metabolism, BDNF, HPA Axis Dysfunction, and Pharmacotherapy Advances

Correia, A. S., & Vale, N. (2024) · International Journal of Translational Medicine · doi:10.3390/ijtm4010010 · Cited by 41 · see citing works

Ketamine can produce oscillatory dynamics by engaging mechanisms dependent on the kinetics of NMDA receptors

Adam, E. M., Kowalski, M., Akeju, O., Miller, E. K., Brown, E. N., McCarthy, M. M., & Kopell, N. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2402732121 · Cited by 35 · see citing works

Ketamine and Calcium Signaling—A Crosstalk for Neuronal Physiology and Pathology

Lisek, M., Żylińska, L., & Boczek, T. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21218410 · Cited by 40 · see citing works

Neurocognitive Effects of Ketamine and Esketamine for Treatment-Resistant Major Depressive Disorder: A Systematic Review

Souza‐Marques, B., Santos‐Lima, C., Araújo-de-Freitas, L., Vieira, F., Jesus‐Nunes, A. P., Quarantini, L. C., & Sampaio, A. S. (2021) · Harvard Review of Psychiatry · doi:10.1097/hrp.0000000000000312 · Cited by 39 · see citing works

Acute treatment with ketamine and chronic treatment with minocycline exert antidepressant-like effects and antioxidant properties in rats subjected different stressful events

Maciel, A. L., Abelaira, H. M., de Moura, A. B., de Souza, T. G., Rosa, T., Matos, D., Tuon, T., Garbossa, L., Strassi, A. P., Fileti, M. E., et al. (2017) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2017.12.005 · Cited by 35 · see citing works

Recent insights into antidepressant therapy: Distinct pathways and potential common mechanisms in the treatment of depressive syndromes

van Calker, D., Serchov, T., Normann, C., & Biber, K. P. H. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.03.014 · Cited by 35 · see citing works

Is (R)-ketamine a potential therapeutic agent for treatment-resistant depression with less detrimental side effects? A review of molecular mechanisms underlying ketamine and its enantiomers

Scotton, E., Antqueviezc, B., Vasconcelos, M., Dalpiaz, G., Géa, L. P., Goularte, J. F., Colombo, R., & Rosa, A. R. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2022.114963 · Cited by 36 · see citing works

Spontaneous respiratory plasticity following unilateral high cervical spinal cord injury in behaving rats

Bezdudnaya, T., Hormigo, K. M., Marchenko, V., & Lane, M. A. (2018) · Experimental Neurology · doi:10.1016/j.expneurol.2018.03.014 · Cited by 34 · see citing works

Maintenance Ketamine Therapy for Treatment-Resistant Depression

Archer, S., Chrenek, C., & Swainson, J. (2018) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000894 · Cited by 33 · see citing works

The ‘Yin’ and the ‘Yang’ of the kynurenine pathway: excitotoxicity and neuroprotection imbalance in stress-induced disorders

Barone, P. R. (2019) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000477 · Cited by 33 · see citing works

Multiple inducers and novel roles of autoantibodies against the obligatory NMDAR subunit NR1: a translational study from chronic life stress to brain injury

Pan, H., Steixner-Kumar, A. A., Seelbach, A., Deutsch, N. R., Ronnenberg, A., Tapken, D., von Ahsen, N., Mitjans, M., Worthmann, H., Trippe, R., et al. (2020) · Molecular Psychiatry · doi:10.1038/s41380-020-0672-1 · Cited by 35 · see citing works

Advances in novel molecular targets for antidepressants

Wang, Q., & Dwivedi, Y. (2020) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.110041 · Cited by 32 · see citing works

The therapeutic role of ketamine and esketamine in treating psychopathological domains of depression

Jawad, M. Y., Vincenzo, J. D. D., Badulescu, S., Teopiz, K. M., Tabassum, A., Ceban, F., Mckenzie, A., Meshkat, S., Rosenblat, J. D., Ho, R., et al. (2022) · Neuropharmacology · doi:10.1016/j.neuropharm.2022.109299 · Cited by 32 · see citing works

Effects of Ketamine on Rodent Fear Memory

Choi, K. H., Berman, R. Y., Zhang, M., Spencer, H. F., & Radford, K. D. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21197173 · Cited by 31 · see citing works

Mechanisms of the Rapid Effects of Ketamine on Depression and Sleep Disturbances: A Narrative Review

Song, B., & Zhu, J. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.782457 · Cited by 31 · see citing works

Molecular Mechanisms of AMPA Receptor Trafficking in the Nervous System

Cao, Y., Ling-Ling, W., Li, X., Yuan, Y.-L., Zhao, W., Qi, J., Zhao, X.-Y., Ward, N., & Wang, J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms25010111 · Cited by 31 · see citing works

A Novel Application of Ketamine for Improving Perioperative Sleep Disturbances

Song, B., & Zhu, J. (2021) · Nature and Science of Sleep · doi:10.2147/nss.s341161 · Cited by 30 · see citing works

Ketamine-Associated Intraoperative Electroencephalographic Signatures of Elderly Patients With and Without Preoperative Cognitive Impairment

Chang, O. L. B., Kreuzer, M., Morgen, D. F., Possin, K. L., & García, P. S. (2022) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000005875 · Cited by 29 · see citing works

Ketamine as a therapeutic agent in major depressive disorder and posttraumatic stress disorder: Potential medicinal and deleterious effects

Sachdeva, B., Sachdeva, P., Ghosh, S., Ahmad, F., & Sinha, J. K. (2023) · Ibrain · doi:10.1002/ibra.12094 · Cited by 29 · see citing works

Storm on predictive brain: A neurocomputational account of ketamine antidepressant effect

Bottemanne, H., Berkovitch, L., Gauld, C., Balcerac, A., Schmidt, L., Mouchabac, S., & Fossati, P. (2023) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2023.105410 · Cited by 28 · see citing works

AMPA receptor-mTORC1 signaling activation is required for neuroplastic effects of LY341495 in rat hippocampal neurons

Seo, M. K., Hiền, L. T. T., Park, M. K., Choi, A. J., Seog, D., Kim, S. H., Park, S. W., & Lee, J. G. (2020) · Scientific Reports · doi:10.1038/s41598-020-58017-3 · Cited by 23 · see citing works

The Glutamatergic System in Treatment-Resistant Depression and Comparative Effectiveness of Ketamine and Esketamine: Role of Inflammation?

Halaris, A. E., & Cook, J. T. (2023) · Advances in experimental medicine and biology · doi:10.1007/978-981-19-7376-5_21 · Cited by 25 · see citing works

Alterations in mGlu5 receptor expression and function in the striatum in a rat depression model

Mao, L., & Wang, J. Q. (2018) · Journal of Neurochemistry · doi:10.1111/jnc.14307 · Cited by 23 · see citing works

Interaction of Sex and Age on the Dissociative Effects of Ketamine Action in Young Healthy Participants

Derntl, B., Hornung, J., Şen, Z. D., Čolić, L., Li, M., & Walter, M. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00616 · Cited by 23 · see citing works

Roles of non-receptor tyrosine kinases in pathogenesis and treatment of depression

Wang, J. Q., Derges, J. D., Bodepudi, A., Pokala, N., & Mao, L. (2022) · Journal of Integrative Neuroscience · doi:10.31083/j.jin2101025 · Cited by 22 · see citing works

Reelin has antidepressant-like effects after repeated or singular peripheral injections

Allen, J., Romay-Tallón, R., Mitchell, M. A., Brymer, K. J., Johnston, J. N., Sánchez-Lafuente, C. L., Pinna, G., Kalynchuk, L. E., & Caruncho, H. J. (2022) · Neuropharmacology · doi:10.1016/j.neuropharm.2022.109043 · Cited by 22 · see citing works

Zelquistinel Is an Orally Bioavailable Novel NMDA Receptor Allosteric Modulator That Exhibits Rapid and Sustained Antidepressant-Like Effects

Burgdorf, J. S., Zhang, X., Stanton, P. K., Moskal, J. R., & Donello, J. E. (2022) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyac043 · Cited by 22 · see citing works

Auxiliary subunits of AMPA receptors: The discovery of a forebrain-selective antagonist, LY3130481/CERC-611

Kato, A., & Witkin, J. M. (2017) · Biochemical Pharmacology · doi:10.1016/j.bcp.2017.09.015 · Cited by 22 · see citing works

Co-administration of cannabidiol and ketamine induces antidepressant-like effects devoid of hyperlocomotor side-effects

Sartim, A. G., Marques, J., Silveira, K. M., Gobira, P. H., Guimarães, F. S., Wegener, G., & Joca, S. R. L. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108679 · Cited by 22 · see citing works

Hydroxynorketamine: Implications for the NMDA Receptor Hypothesis of Ketamine’s Antidepressant Action

Aleksandrova, L. R., Wang, Y. T., & Phillips, A. G. (2017) · Chronic Stress · doi:10.1177/2470547017743511 · Cited by 21 · see citing works

Tianeptine antagonizes the reduction of PV+ and GAD67 cells number in dorsal hippocampus of socially isolated rats

Perić, I., Stanisavljević, A., Inta, D., Gass, P., Lang, U. E., Borgwardt, S., & Filipović, D. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2018.10.013 · Cited by 19 · see citing works

AMPA receptors mediate the pro-cognitive effects of electrical and optogenetic stimulation of the medial prefrontal cortex in antidepressant non-responsive Wistar–Kyoto rats

Papp, M., Gruca, P., Łasoń, M., Litwa, E., Solecki, W., & Willner, P. (2020) · Journal of Psychopharmacology · doi:10.1177/0269881120967857 · Cited by 21 · see citing works

Strategies for Treatment-Resistant Depression: Lessons Learned from Animal Models

Réus, G. Z., de Moura, A. B., Borba, L. A., Abelaira, H. M., & Quevedo, J. (2019) · Complex Psychiatry · doi:10.1159/000500324 · Cited by 21 · see citing works

The neuroprotective effect and possible therapeutic application of xenon in neurological diseases

Zhang, M., Cui, Y., Cheng, Y., Wang, Q., & Sun, H. (2021) · Journal of Neuroscience Research · doi:10.1002/jnr.24958 · Cited by 20 · see citing works

Indices of cortical plasticity after therapeutic sleep deprivation in patients with major depressive disorder

Kühn, M., Maier, J. G., Wolf, E., Mainberger, F., Feige, B., Maywald, S., Bredl, A., Michel, M., Sendelbach, N., Normann, C., et al. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.08.052 · Cited by 20 · see citing works

Stress and Ketamine, Bimodal Influence on Cognitive Functions

Trofimiuk, E., Wielgat, P., Braszko, J. J., & Car, H. (2018) · Behavioural Brain Research · doi:10.1016/j.bbr.2018.12.030 · Cited by 19 · see citing works

Sleep Disturbances and Depression Are Co-morbid Conditions: Insights From Animal Models, Especially Non-human Primate Model

Li, M., Cui, J., Xu, B., Wei, Y., Fu, C., Lv, X., Xiong, L., & Qin, D. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.827541 · Cited by 19 · see citing works

Effective Use of Animal Models for Therapeutic Development in Psychiatric and Substance Use Disorders

Phillips, A. G., Geyer, M. A., & Robbins, T. W. (2018) · Biological Psychiatry · doi:10.1016/j.biopsych.2018.01.014 · Cited by 19 · see citing works

The novel methoxetamine analogs N-ethylnorketamine hydrochloride (NENK), 2-MeO-N-ethylketamine hydrochloride (2-MeO-NEK), and 4-MeO-N-ethylketamine hydrochloride (4-MeO-NEK) elicit rapid antidepressant effects via activation of AMPA and 5-HT2 receptors

Sayson, L. V., Botanas, C. J., Custodio, R. J. P., Abiero, A., Kim, M., Lee, H. J., Kim, H. J., Yoo, S. Y., Lee, K. W., Ryu, H. W., et al. (2019) · Psychopharmacology · doi:10.1007/s00213-019-05219-x · Cited by 19 · see citing works

Vascular endothelial growth factor and pigment epithelial-derived factor in the peripheral response to ketamine

McGrory, C. L., Ryan, K. M., Gallagher, B., & McLoughlin, D. M. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.04.013 · Cited by 19 · see citing works

Transcranial magnetic stimulation and ketamine: implications for combined treatment in depression

Dębowska, W., Więdłocha, M., Dębowska, M. D., Kownacka, Z., Marcinowicz, P., & Szulc, A. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1267647 · Cited by 21 · see citing works

Effects of ketamine on orientation selectivity and variability of neuronal responses in primary visual cortex

Ouelhazi, A., Bharmauria, V., Chanauria, N., Bachatene, L., Lussiez, R., & Molotchnikoff, S. (2019) · Brain Research · doi:10.1016/j.brainres.2019.146462 · Cited by 16 · see citing works

Treatment of cholinergic‐induced status epilepticus with polytherapy targeting GABA and glutamate receptors

Niquet, J., Nguyen, D. A., Furtado, M. D. A., & Lumley, L. A. (2023) · Epilepsia Open · doi:10.1002/epi4.12713 · Cited by 17 · see citing works

Genetic modulation of the HTR2A gene reduces anxiety-related behavior in mice

Rohn, T., Radin, D., Brandmeyer, T., Linder, B. J., Andriambeloson, E., Wagner, S., Kehler, J., Vasileva, A., Wang, H.-E., Mee, J. L., et al. (2023) · PNAS Nexus · doi:10.1093/pnasnexus/pgad170 · Cited by 16 · see citing works

Biodistribution and radiation dosimetry of the positron emission tomography probe for AMPA receptor, [11C]K-2, in healthy human subjects

Hatano, M., Miyazaki, T., Ishiwata, Y., Nakajima, W., Arisawa, T., Kuroki, Y., Kobayashi, A., Takada, Y., Ogawa, M., Kawamura, K., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-81002-3 · Cited by 17 · see citing works

Age affects temporal response, but not durability, to serial ketamine infusions for treatment refractory depression

Pennybaker, S. J., Roach, B. J., Fryer, S. L., Badathala, A., Wallace, A., Mathalon, D. H., & Marton, T. F. (2021) · Psychopharmacology · doi:10.1007/s00213-021-05939-z · Cited by 17 · see citing works

The roles of neuroinflammation and glutamatergic excitotoxicity in treatment-resistant depression

Candee, R., Wilkenson, R., Schreiber, M., & Decenzo, M. (2023) · JAAPA : official journal of the American Academy of Physician Assistants · doi:10.1097/01.jaa.0000921252.57819.4b · Cited by 9 · see citing works

The role of mGluR5 on the therapeutic effects of ketamine in Wistar rats

Gokalp, D., & Ünal, G. (2024) · Psychopharmacology · doi:10.1007/s00213-024-06571-3 · Cited by 16 · see citing works

Agmatine as a potential therapeutic intervention in bipolar depression: the preclinical landscape

Watts, D., Pfaffenseller, B., Wollenhaupt-Aguiar, B., Géa, L. P., Cardoso, T. D. A., & Kapczinski, F. P. (2019) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2019.1581764 · Cited by 16 · see citing works

Gene expression signature of antidepressant treatment response/non-response in Flinders Sensitive Line rats subjected to maternal separation

Marchetti, L., Lauria, M., Caberlotto, L., Musazzi, L., Popoli, M., Mathé, A. A., Domenici, E., & Carboni, L. (2019) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2019.11.004 · Cited by 17 · see citing works

Antidepressant Actions of Ketamine: Potential Role of L-Type Calcium Channels

Robinson, B. L., Gu, Q., & Kanungo, J. (2021) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.0c00411 · Cited by 16 · see citing works

Gender-Specific Effects of Two Treatment Strategies in a Mouse Model of Niemann-Pick Disease Type C1

Holzmann, C., Witt, M., Rolfs, A., Antipova, V., & Wree, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052539 · Cited by 16 · see citing works

Antidepressant effects of repeated s-ketamine administration as NMDAR Antagonist: Involvement of CaMKIIα and mTOR signaling in the hippocampus of CUMS mice

Liu, B., Du, Y., Xu, C. S., Liu, Q., & Zhang, L. (2023) · Brain Research · doi:10.1016/j.brainres.2023.148375 · Cited by 16 · see citing works

Hippocampal Acetylation may Improve Prenatal-Stress-Induced Depression-Like Behavior of Male Offspring Rats Through Regulating AMPARs Expression

Lu, Y., Zhang, J., Zhang, L., Dang, S., Su, Q., Zhang, H., Lin, T., Zhang, X., Zhang, Y., Sun, H., et al. (2017) · Neurochemical Research · doi:10.1007/s11064-017-2393-7 · Cited by 17 · see citing works

Ketamine alleviates fear memory and spatial cognition deficits in a PTSD rat model via the BDNF signaling pathway of the hippocampus and amygdala

Teng, Y., Niu, J., Liu, Y., Wang, H., Chen, J., Kong, Y., Wang, X., Lian, B., Wang, W., Sun, H., et al. (2023) · Behavioural Brain Research · doi:10.1016/j.bbr.2023.114792 · Cited by 17 · see citing works

Revealing brain mechanisms of mTOR-mediated translational regulation: Implications for chronic pain

Cho, C., Michailidis, V., & Martin, L. J. (2018) · Neurobiology of Pain · doi:10.1016/j.ynpai.2018.03.002 · Cited by 15 · see citing works

The NMDA receptor antagonists memantine and ketamine as anti-migraine agents

Podkowa, K., Czarnacki, K., Borończyk, A., Borończyk, M., & Paprocka, J. (2023) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-023-02444-2 · Cited by 15 · see citing works

The rapid‐onset antidepressant effect of ketamine: More surprises?

Raffa, R. B., Pergolizzi, J. V., & Taylor, R. (2017) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/jcpt.12656 · Cited by 5 · see citing works

Mechanisms of ketamine action as an antidepressant

Zanos, P., & Gould, T. D. (2018) · Molecular Psychiatry · doi:10.1038/mp.2017.255 · Cited by 1,127 · see citing works

NMDAR inhibition-independent antidepressant actions of ketamine metabolites

Morris, P. J., Yuan, P., Fang, Y., Mayo, C. L., Huang, X., Gould, T. D., Dossou, K. S. S., Moaddel, R., Wainer, I. W., Thomas, C. J., et al. (2020) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/wfvq-kk18

Ketamine and other potential glutamate antidepressants

Dutta, A., McKie, S., & Deakin, J. F. W. (2014) · Psychiatry Research · doi:10.1016/j.psychres.2014.10.028 · Cited by 89 · see citing works

Cellular Mechanisms Underlying the Antidepressant Effects of Ketamine: Role of α-Amino-3-Hydroxy-5-Methylisoxazole-4-Propionic Acid Receptors

Maeng, S., Zarate, C. A., Du, J., Schloesser, R. J., McCammon, J., Chen, G., & Manji, H. K. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.05.028 · Cited by 1,103 · see citing works